User profiles for Marco Contoli
 | Marco ContoliUniversity of Ferrara - Italy Verified email at unife.it Cited by 8447 |
Role of deficient type III interferon-λ production in asthma exacerbations
M Contoli, SD Message, V Laza-Stanca, MR Edwards… - Nature medicine, 2006 - nature.com
Rhinoviruses are the major cause of asthma exacerbations, and asthmatics have increased
susceptibility to rhinovirus and risk of invasive bacterial infections. Here we show deficient …
susceptibility to rhinovirus and risk of invasive bacterial infections. Here we show deficient …
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients
…, G Caramori, I Gnemmi, M Contoli… - Clinical & …, 2009 - academic.oup.com
There are increased numbers of activated T lymphocytes in the bronchial mucosa of stable
chronic obstructive pulmonary disease (COPD) patients. T helper type 17 (Th17) cells …
chronic obstructive pulmonary disease (COPD) patients. T helper type 17 (Th17) cells …
Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production
…, J Zhu, T Kebadze, M Contoli… - Proceedings of the …, 2008 - National Acad Sciences
Acute exacerbations are the major cause of asthma morbidity, mortality, and health-care costs
and are difficult to treat and prevent. The majority of asthma exacerbations are associated …
and are difficult to treat and prevent. The majority of asthma exacerbations are associated …
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation
Rationale: Respiratory virus infections are associated with chronic obstructive pulmonary
disease (COPD) exacerbations, but a causative relationship has not been proven. Studies of …
disease (COPD) exacerbations, but a causative relationship has not been proven. Studies of …
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease
…, J Footitt, R Sotero, A Jepson, M Contoli… - American journal of …, 2012 - atsjournals.org
Rationale: Chronic obstructive pulmonary disease (COPD) exacerbations are associated
with virus (mostly rhinovirus) and bacterial infections, but it is not known whether rhinovirus …
with virus (mostly rhinovirus) and bacterial infections, but it is not known whether rhinovirus …
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact
In chronic obstructive pulmonary disease (COPD), exacerbations (ECOPD), characterized
by an acute deterioration in respiratory symptoms, are fundamental events impacting …
by an acute deterioration in respiratory symptoms, are fundamental events impacting …
[HTML][HTML] Markers of endothelial and epithelial pulmonary injury in mechanically ventilated COVID-19 ICU patients
Background Biomarkers can be used to detect the presence of endothelial and/or alveolar
epithelial injuries in case of ARDS. Angiopoietin-2 (Ang-2), soluble intercellular adhesion …
epithelial injuries in case of ARDS. Angiopoietin-2 (Ang-2), soluble intercellular adhesion …
Deficient antiviral immune responses in childhood: distinct roles of atopy and asthma
BACKGROUND: Impaired immune response to viral infections in atopic asthmatic patients
has been recently reported and debated. Whether this condition is present in childhood and …
has been recently reported and debated. Whether this condition is present in childhood and …
Minimal clinically important difference for asthma endpoints: an expert consensus report
…, M Caminati, E Carpagnano, M Contoli… - European …, 2020 - Eur Respiratory Soc
Minimal clinically important difference (MCID) can be defined as the smallest change or
difference in an outcome measure that is perceived as beneficial and would lead to a change in …
difference in an outcome measure that is perceived as beneficial and would lead to a change in …
[HTML][HTML] Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort …
B Fritzsching, M Contoli, C Porsbjerg… - The Lancet Regional …, 2022 - thelancet.com
Background Allergen immunotherapy (AIT) is the only causal treatment for respiratory allergy.
Long-term real-life effectiveness of AIT remains to be demonstrated beyond the evidence …
Long-term real-life effectiveness of AIT remains to be demonstrated beyond the evidence …